Related Experiment Video
Updated: Aug 26, 2026
A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset (Callithrix jacchus)
Published on: February 27, 2018
Intratympanic gentamicin for intractable Meniere's disease: 5-year follow-up
1Department of Otolaryngology, University of Western Ontario, London, Ontario.
Objective:
To determine the efficacy and morbidity of intratympanic gentamicin titration therapy on patients with incapacitating unilateral Meniere's disease.
Method:
The study consisted of a retrospective chart review and patient interviews. Sixty-eight patients had been followed for a minimum of 24 months and were reported on in an earlier study. Forty-six of these individuals were available for detailed follow-up at 5 years post-gentamicin therapy.
Main Outcome Measures:
Vertigo frequency, hearing status, personal disability ratings, and tinnitus level before and after gentamicin therapy were measured.
Results:
Seventy-four percent of patients showed complete vertigo control and an additional 7% showed substantial vertigo control. There was also significant improvement in personal ratings of social and economic functioning. Overall, the group showed no combined statistically significant changes in any of the hearing parameters.
Conclusion:
Intratympanic gentamicin titration therapy provides excellent vertigo control, with a similarly significant improvement in both personal and occupational functioning.
